Prevention of Dementia: Kristine Yaffe
May 11, 2023
We’ve had multiple GeriPal episodes about treatments for dementia, including aducanumab (here, here, and here) and lecanemab (here). As today’s…
Transforming the Culture of Dementia Care: Podcast with Anne Basting, Ab Desai, Susan McFadden, and Judy Long
December 2, 2022
What would it take to transform dementia care? While a lot of hope and money is being put into new…
Private Equity Gobbling Up Hospices plus Hospice and Dementia: Melissa Aldridge, Krista Harrison, & Lauren Hunt
August 25, 2022
Two major shifts are transforming the landscape of hospice. First, private equity firms are gobbling up hospices. As Melissa Aldridge,…
Time to stop driving? Podcast with Emmy Betz and Terri Cassidy
July 21, 2022
The science of balancing safety and independence of older drivers has come a long way. Some key points from our…
Dementia and high risk surgery: Joel Weissman and Samir Shah
June 30, 2022
You have a patient with dementia severe enough that she cannot recognize relatives. She falls and breaks her hip. Should…
Meaningful Activities: Podcast with Anna Oh and Theresa Allison
October 28, 2021
Most studies in geriatrics have used metrics such as survival time or disability in activities of daily living as their…
“Real world” eligibility for aducanumab: A Podcast with Tim Anderson and Marco Canevelli
October 21, 2021
The FDA label for the amyloid antibody aducanumab (Aduhelm) started off exceedingly broad, basically including anyone with Alzheimer’s disease, but…
Aducanumab (Aduhelm) for the Treatment of Alzheimers: A Podcast with Aaron Kesselheim and Jason Karlawish
July 29, 2021
On June 7th, 2021 FDA approved the amyloid beta-directed antibody aducanumab (Aduhelm) for the Treatment of Alzheimers. This approval of…
Polypharmacy and Deprescribing Super Special: Podcast with Anna Parks, Matthew Growdon, and Mike Steinman
July 15, 2021
In a new study in JAGS, Matthew Growdon found that the average number of medications people with dementia took in…
All things Amyloid, including Aducanumab and Amyloid PET scans with Gil Rabinovici
April 15, 2021
There are no currently approved disease modifying drugs for Alzheimer’s disease, but in a couple months that may change. In July…